To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Wave Life Sciences is rated Hold, reflecting high pipeline potential but significant clinical, regulatory, and commercial ...

PORTLAND, Ore. (KOIN) — An injured logger was successfully rescued from the Alsea Falls Recreation Area in Oregon Friday morning, authorities said. The accident was reported just after 11:30 a.m., ...

Runway AI Inc. today announced that it has closed a $315 million funding round backed by Nvidia Corp. and AMD Ventures. The lead investor was General Atlantic, which was also the biggest contributor ...

Looking for ways to make some extra money this year? We've compiled a list of different passive income ideas to spark inspiration, including investing, real estate and a few niche options, like ...

When signing in to Windows, a password is the default option. But remembering a strong and complex password can be a hassle. Instead, you can try biometric technologies supported through the Windows ...